To achieve this, we produced Cyp17a1 KO rats and verified their obesity phenotype, assessing key components of metabolic syndrome including blood glucose levels, blood pressure, glucose tolerance, and insulin resistance. This evidence concerns the gene CYP17A1 and obesity due to melanocortin 4 receptor deficiency.